 |
|
Long-term Survival Following Induction Chemoradiotherapy and Esophagectomy for Esophageal Carcinoma—Invited Critique
Francis G. Duhaylongsod, MD
Honolulu, Hawaii
Arch Surg. 2001;136:743.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
This year, over 12 000 new cases of esophageal cancer will be diagnosed in the United States. Despite curative resection, nearly 90% of patients will die of the disease. This has provided investigators the impetus to examine whether induction chemoradiotherapy (CRT) followed by surgery is beneficial in patients with resectable esophageal cancer. Currently, only 4 prospective randomized trials have been published.1-4 The 3-year survival reported was 17% to 32% in patients receiving CRT and surgery vs 6.0% to 13.8% in patients receiving surgery alone1-4 Only 1 of the 4 trials, however, demonstrated a significant benefit in overall survival with CRT and surgery.4
Lew and colleagues have had considerable experience with induction CRT and surgery for resectable esophageal cancer. Their study, comparing patients receiving an induction CRT protocol in addition to surgery with patients receiving just surgery, found that with a median follow-up of about 4 years, 12 . . . [Full Text of this Article]
RELATED ARTICLE
Long-term Survival Following Induction Chemoradiotherapy and Esophagectomy for Esophageal Carcinoma
John I. Lew, William E. Gooding, Ulysses Ribeiro, Jr, Adriana V. Safatle-Ribeiro, and Mitchell C. Posner
Arch Surg. 2001;136(7):737-742.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Prospective Analysis of Accuracy of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasonography in Staging of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
Rasanen et al.
Ann. Surg. Oncol. 2003;10:954-960.
ABSTRACT
| FULL TEXT
|
